Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

Abroad (travel likely)Recruiting

Conditions

Alcohol-related Liver Disease · Liver Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Henry Ford Health, Detroit, Michigan, United States
Contact: Study coordinator (Matthew Melican) · mmelica1@hfhs.org · 3138744656
Contact: Study coordinator (Jessica Mellinger) · jmellin2@hfhs.org
Contact: Principal Investigator (Jessica Mellinger, MD, MSc)

Study leads

Jessica Mellinger, MD, MSc
Principal Investigator
Henry Ford Health System

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Fecal Microbiota Transplantation

Crohn Disease · Ulcerative Colitis · Celiac Disease

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Non-Alcoholic Fatty Liver Disease · Non-Alcoholic Steatohepatitis · Alcohol-related Liver Disease

Abroad (travel likely)Recruiting

Nice, France

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Liver Diseases, Alcoholic

Abroad (travel likely)RecruitingPHASE2

Chandler, United States · Phoenix, United States

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

Liver Diseases, Alcoholic · Alcohol Use Disorder · Treatment Adherence

Abroad (travel likely)Recruiting

Køge, Denmark